These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3054319)

  • 1. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays.
    Asselin WM; Leslie JM; McKinley B
    J Anal Toxicol; 1988; 12(4):207-15. PubMed ID: 3054319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT).
    Lewellen LJ; McCurdy HH
    J Anal Toxicol; 1988; 12(5):260-4. PubMed ID: 2906382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for amphetamines, barbiturates, methadone, methaqualone, phencyclidine, and propoxyphene.
    Klinger RA; Blum LM; Rieders F
    J Anal Toxicol; 1990; 14(5):288-91. PubMed ID: 2263063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of Emit assay reagents for improved sensitivity and cost effectiveness in the analysis of hemolyzed whole blood.
    Asselin WM; Leslie JM
    J Anal Toxicol; 1992; 16(6):381-8. PubMed ID: 1293406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Triage panel for drugs of abuse to forensic blood samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1996 Apr; 50(2):50-6. PubMed ID: 8691649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an automated microplate enzyme immunoassay for screening of postmortem blood for drugs of abuse.
    Spiehler VR; Collison IB; Sedgwick PR; Perez SL; Le SD; Farnin DA
    J Anal Toxicol; 1998; 22(7):573-9. PubMed ID: 9847007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y; Ojanperä I; Rasanen I; Vuori E
    Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Setting cutoff concentrations for immunoassay screening of postmortem blood.
    Collison IB; Spiehler VR; Guluzian S; Sedgwick PR
    J Forensic Sci; 1998 Mar; 43(2):390-4. PubMed ID: 9544549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.
    Kerrigan S; Phillips WH
    Clin Chem; 2001 Mar; 47(3):540-7. PubMed ID: 11238309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for drugs in forensic blood samples using EMIT urine assays.
    Gjerde H; Christophersen AS; Skuterud B; Klemetsen K; Mørland J
    Forensic Sci Int; 1990 Feb; 44(2-3):179-85. PubMed ID: 2180797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981.
    Mason AP; McBay AJ
    J Forensic Sci; 1984 Oct; 29(4):987-1026. PubMed ID: 6502125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.